NDC 72162-2247-02 - Sodium Sulfacetamide 8% and Sulfur 4% Cleanser
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 72162-2247
- Requested NDC
- 72162-2247-02
- Package NDCs from labels
- 72162-2247-2, 72162-2247-02
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2026-03-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Sodium Sulfacetamide 8% and Sulfur 4% Cleanser - Bryant Ranch Prepack | Bryant Ranch Prepack | 2026-03-19 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72162-2247-2 | Sodium Sulfacetamide 8% and Sulfur 4% Cleanser | 473 mL in 1 BOTTLE, PLASTIC | LIQUID | 473 | 101 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 72162-2247 | SODIUM SULFACETAMIDE 8% AND SULFUR 4% CLEANSER (SULFACETAMIDE SODIUM, SULFUR) LIQUID [BRYANT RANCH PREPACK] | 100 | Current NDC, 1 package rows | 20240131_fb0c9508-0ff1-46eb-8df0-4bfd2c123187.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72162-2247-2 | ML - Milliliter | 72162-2247 | 3e3a5758-2d11-4b82-9ead-b7beef48da0f | 1 | 2024-03-12 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lights Lemon Glycerin | GLYCERIN | Lights Medical Manufacture Co., Ltd. | c38638af-f367-4780-8295-022d959e79ca | 2026-11-09 | Warnings | PDC6A3C0OX |
| Sulfur Clearing Solution | 4% SULFUR SOLUTION | Banuskin, Inc. | 5fa185b9-35eb-f2dd-e063-6394a90acc92 | 2026-11-06 | Warnings | 70FD1KFU70 |
| Glycerin | GLYCERIN | Beijing Jingfeng Pharmaceutical (Shandong) Co., Ltd | 552e16b9-f46a-7838-e063-6394a90ab8aa | 2026-11-04 | Warnings | PDC6A3C0OX |
| Lemon Glycerine Swabsticks | GLYCERINE | PHOENIX HEALTHCARE SOLUTIONS, LLC | 436919f7-14cd-4318-9388-b3e1cbec176b | 2026-11-03 | Warnings | PDC6A3C0OX |
| hemorrhoidal | GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM | Shield Line LLC | 5f635795-cb5b-cab4-e063-6394a90a7a9a | 2026-11-03 | Warnings | PDC6A3C0OX |
| Stage Fight Acne Mask | SULFUR, RESORCINOL | Cosmetic Enterprises Ltd | 209e321e-ed20-9c67-e063-6394a90a5410 | 2026-11-03 | Warnings | 70FD1KFU70 |
| Huddle Barrier Balm | GLYCERIN | Better Barrier Co. | 5b3cf1ed-082b-15cf-e063-6394a90a688e | 2026-11-02 | Warnings | PDC6A3C0OX |
| Prosacea | SULPHUR | Kobayashi Healthcare International, Inc. | e5907672-3ee1-44d3-9c92-6345ad3f4238 | 2026-10-30 | Warnings | 70FD1KFU70 |
| ENCON EYEWASH | EYEWASH | Encon Safety Products, Inc. | 485c691e-f6a8-4836-e063-6294a90a16fc | 2026-10-29 | Warnings | 059QF0KO0R |
| Stage Fight Acne Mask | SULFUR, RESORCINOL | Bioelements, Inc | 21ca8de4-28b5-425f-e063-6394a90a3340 | 2026-10-27 | Warnings | 70FD1KFU70 |
| Glycerin | GLYCERIN | Chain Drug Marketing Association Inc. | 424d91f0-ecf9-6d9b-e063-6394a90a8006 | 2026-10-26 | Warnings | PDC6A3C0OX |
| Family Wellness HEMORRHOID | GLYCERIN, PETROLATUM, PHENYLEPHRINE HCL, PRAMOXINE HCL | FAMILY DOLLAR (Family Wellness) | 16ceb129-5c0a-428a-a867-cfbbb08bb62a | 2026-10-26 | Warnings | PDC6A3C0OX |
| Bacteriostatic Water | WATER | Henry Schein, Inc. | a833502e-a622-4e81-8c58-cef6ccb6c4c9 | 2026-10-26 | Boxed warning, Warnings, Adverse reactions | 059QF0KO0R |
| Optase | GLYCERIN | Scope Health Inc | d81c1a4f-87b0-ee8c-e053-2995a90af9e5 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 9e96976b-2990-79e0-e053-2995a90a0f29 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 376e0289-28e9-e87f-e063-6294a90a3b04 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | f452a2c4-c869-7bf5-e053-2995a90ac1a0 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 10c3e31d-779d-8ff6-e063-6294a90acd39 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 86c14327-ffc7-806e-e053-2991aa0aaf92 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Clear Eyes Maximum Redness Relief | NAPHAZOLINE HYDROCHLORIDE AND GLYCERIN | Prestige Brands Holdings, Inc. | c3b0e344-68dd-4c35-bf46-744e612a5b15 | 2026-10-23 | Warnings | PDC6A3C0OX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.